Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: The potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge

European Journal of Heart Failure

Volumn 3, Issue 2, 2001, Pages 209-215

  McDonald, Kenneth ^a,b   Ledwidge, Mark ^b,c   Cahill, John ^a   Kelly, Jean ^a   Quigley, Peter ^a   Maurer, Brian ^a   Begley, Fiona ^a   Ryder, Mary ^a   Travers, Bronagh ^a   Timmons, Lorna ^a,b   Burke, Teresa ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b IRISH HEART FOUNDATION   (Ireland)

^c Servier Laboratories   (Ireland)

Author keywords

Angiotensin converting enzyme inhibitor; Discharge stability; Early readmission; Heart failure; Multidisciplinary care

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; ELDERLY CARE; FEMALE; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT DISCHARGE; PATIENT READMISSION; PERINDOPRIL; RECURRENCE; RISK FACTORS; SURVIVAL RATE;

EID: 0035103894     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(00)00134-3     Document Type: Article

References (26)

1. Impact of a comprehensive heart failure program on hospital readmission and functional status of participants with advanced heart failure
2. Effect of a heart failure program on hospitalization frequency and exercise tolerance
3. Specialized centers for heart failure management
4. A multidisciplinary intervention to prevent the readmission of elderly participants with congestive heart failure
5. Effects of a multidiscplinary, home based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure
6. The heart failure epidemic: Magnitude of the problem and potential mitigating approaches
7. Trends for hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence
8. The association between quality of inpatient care and early readmission
9. Early readmission of elderly participants with congestive heart failure
10. Simple clinical variables are markers of the propensity for early readmission in heart failure patients
11. Correlates of early hospital readmission or death in patients with congestive heart failure
12. Effects of education and support on self-care and resource utilization in patients with heart failure
13. Does increased access to primary care reduce hospital readmissions
14. Successes and failures in the treatment of heart failure
15. Heart failure disease management: A critical review
16. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin converting enzyme inhibitors in congestive heart failure
17. First dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: A Malaysian experience
18. Angiotensin converting enzyme inhibitors in heart failure: Target dose prescription in elderly patients
19. The independent effects of left ventricular ejection fraction on short term outcomes and resource utilisation following hospitalisation for heart failure
20. Perindopril for elderly patients with chronic heart failure: PEP-CHF study
21. ACE inhibitors for the prevention and treatment of heart failure: Why are they 'under-used'?
22. Undertreatment of older patients with congestive heart failure
23. Consensus recommendations for the management of chronic heart failure
24. Differences in generalist and specialist physicians knowledge and use of angiotensin converting enzyme inhibitors for the treatment of congestive heart failure
25. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalisation rates in congestive heart failure
26. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure